期刊文献+

Rab5a和APPLl在乳腺癌组织中的表达及意义 被引量:6

Expression and significance of RabSa and APPLI in breast cancer
原文传递
导出
摘要 目的探讨Rah5a和APPLl在乳腺癌组织中的表达及意义。方法采用免疫组织化学方法检测柏例乳腺纤维瘤组织和74例乳腺癌组织中Rab5a和APPLl的表达水平,分析其与乳腺癌转移、病理分级和人表皮生长因子受体2(HER-2)表达的相关性。结果Rah5a和APPLl在乳腺纤维瘤组织中的阳性率分别为45.O%和30.0%,在乳腺癌组织中的阳性率分别为91.9%和83.8%(均P〈0.01)。Rab5a在乳腺癌HER-2阳性组和阴性组中的阳性率分别为92.6%和90.0%(P〈0.05),APPLl在乳腺癌HER-2阳性组和阴性组中的阳性率分别为85.2%和80.0%(P〉0.05)。Rab5a和APPLl在有无乳腺癌局部转移和不同病理学分级中的表达差异无统计学意义(P〉0.05)。结论Rab5a和APPLl在乳腺癌中高表达,并与HER-2表达呈正相关;Rab5a和APPLl可能通过调节HER-2的信号传导而影响乳腺癌细胞生物学行为。 Objective To investigate the expression of RabSa and APPL1 in breast cancer and fibroma, and analyze their correlation with HER-2 expression, metastasis and development of breast cancer. Methods RabSa and APPL1 in paraffin embedded tissues of 74 breast carcinomas and 40 breast fibromas were detected by immunohistochemistry. Their relationship with metastasis, pathological grade, and HER-2 expression in breast cancer was determined by statistical analysis. Results There was no expression or low expression of RakSa and APPL1 in the breast fibroma, but the positive expression rate of RabSa and APPL1 in the breast carcinomas were 91.9% and 83.8%, respectively. No significant difference in expression of RabSa and APPL1 was found between metastatic and non-metastatic groups, and pathological grade Ⅰ/ Ⅱ and grade Ⅲ groups. But RahSa was overexpressed in HER-2-positive group compared with that in the HER- 2-negative group. Conclusions Rab.Sa and APPL1 are overexpressed in breast cancer, and are positively correlated with the HER-2 expression. These proteins may influence the growth and proliferation of breast cancer cells by HER-2 signal transduction.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第11期838-841,共4页 Chinese Journal of Oncology
基金 上海市闵行区科委资助项目(2008MH024) 上海市科委基金资助项目(08411964300)
关键词 乳腺肿瘤 RAB5A APPL1 人表皮生长因子受体2 免疫组织化学 Breast neoplasms RabSa APPL1 Human epidermal growth factor receptor-2 Immunohistochemistry
  • 相关文献

参考文献13

  • 1王言,姚璐,刘毅强,徐晔,欧阳涛,李金锋,王天峰,范照青,范铁,林本耀,解云涛.人表皮生长因子受体2表达对腋淋巴结阳性和阴性乳腺癌患者预后的不同影响[J].中华肿瘤杂志,2010,32(7):511-514. 被引量:10
  • 2张慧明,张保宁,宣立学,赵平.可手术的不同分子亚型乳腺癌的临床特征和生存分析[J].中华肿瘤杂志,2009,31(6):447-451. 被引量:30
  • 3Zhao Z,Liu XF, Wu HC, et al. Rab5a overexpression promotingovarian cancer cell proliferation may be associated with APPL1 -related epidermal growth factor signaling pathway. Cancer Sci,2010,101:1454-1462.
  • 4谢蕴,赵缜,浦文兰.Rab5a与胃腺癌发生和发展的关系[J].中华消化杂志,2010,30(7):485-486. 被引量:1
  • 5Mitra S,Cheng KW, Mills GB. Rab GTPases implicated in inheritedand acquired disorders. Semin Cell Dev Biol, 2011,22:57-68.
  • 6Schenck A,Goto-Silva L,Collinet C,et al. The Endosomal proteinappll mediates Akt substrate specificity and cell survival invertebrate development. Cell, 2008 , 133 -.486-497.
  • 7Banach-Orlowska M, Pilecka I,Tarun A, et al. Functional characteri-zation of the interactions between endosomal adaptor protein APPL1and the NuRD co-repressor complex. Biochem J, 2009,423 :389-400.
  • 8Barbieri MA,Femandez-Pol S,Hunker C, et al. Role of rab5 inEGF receptor-mediated signal transduction. Eur J Cell Biol,2004, 83:305-314.
  • 9Miaczynska M, Christoforidis S, Giner A, et al. APPL proteinslink Rab5 to nuclear signal transduction via an endosomalcompartment. Cell, 2004, 116:445-456.
  • 10Rashid S, Pilecka I,Torun A, et al. Endosomal adaptor proteinsAPPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription. J Biol Chem, 2009, 284: 18115-18128.

二级参考文献35

共引文献38

同被引文献53

  • 1徐蕾,白中红,许软成,闫辉,王方聚,罗荣城.Her-2、EGFR、PS-2、ER在乳腺癌中的表达及其临床意义[J].南方医科大学学报,2006,26(2):231-233. 被引量:5
  • 2胡秀娟,刘贻娟,沙立民,邓卫警.应对方式对恶性肿瘤患者生活质量的影响及护理对策[J].国际护理学杂志,2006,25(3):186-188. 被引量:29
  • 3徐美林,刘岩,钟镐镐,吴秉铨.非小细胞肺癌表皮生长因子受体突变的检测及临床病理意义[J].中华病理学杂志,2007,36(7):453-456. 被引量:9
  • 4Mahlungulu SN,UysLR. Spirituality in nursing: an analysis of the eoneept[J].Curationis, 2004,27(2) :15-26.
  • 5O'Brien F, Mooney M, Glaeken M. Impressions of nursing be- fore exposure to the fieldEJ~. J Clin Nuts,2008,17(14) :1843- 1850.
  • 6Diduk SV,Smirnova KV,Gurtsevich VE.COX-2 as an early diagnostic marker of virus-associated human malignant neoplasms[J].Vopr Virusol,2012,57(2):4-8.
  • 7Bilecová-Rabajdová M,Varga J,Urban P,et al.New and clinically used oncomarkers of bladder cancer[J].Klin Onkol,2012,25(3):162-165.
  • 8Orosz E,Ember I,Combos K,et al.Need for developing a new strategy in the follow-up of colorectal cancer patients; the micro RNAs (miRNAs),as potential new biomarkers of early detection[J].Magy Onkol,2012,56(2):93-102.
  • 9Levenson W.Biomarkers for early detection of breast cancer:what,when,and where[J].Biochim Biophys Acta,2007,1770(6):847-856.
  • 10Lu H,Goodell V,Disis M L.Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer[J].J Proteome Res,2008,7(4):1388-1394.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部